Aviptadil
- Generic Name
- Aviptadil
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C145H232N40O43S
- CAS Number
- 40077-57-4
- Unique Ingredient Identifier
- A67JUW790C
- Associated Conditions
- -
- Associated Therapies
- -
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
Phase 3
Completed
- Conditions
- Covid19
- Interventions
- Drug: Remdesivir PlaceboBiological: RemdesivirDrug: Aviptadil PlaceboBiological: AviptadilDrug: Corticosteroid
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2023-05-03
- Target Recruit Count
- 473
- Registration Number
- NCT04843761
- Locations
- 🇺🇸
VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street, Loma Linda, California, United States
🇺🇸Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza, Los Angeles, California, United States
🇺🇸Cleveland Clinic Fairview Hosptial (Site 207-005), 18101 Lorain Ave., Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath